Nifty

:

24013.10

Sensex

:

76802.90

-154.90 (-0.64%)
-607.08 (-0.78%)

Login

Nifty
Sensex

:
:

24013.10
76802.90

-154.90 (-0.64%)
-607.08 (-0.78%)

IOL Chemicals And Pharmaceuticals Ltd.

Pharmaceuticals & Drugs - API

Rating :

64/99

BSE: 524164 | NSE: IOLCP

Watchlist

NSE BSE

130.21

19-Jun-2026

Open
High
Low
Previous Close

128.3
131.71
126.97
128.30

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1066231
138804735.76
139.99
67.19

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,823.20
27.78
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,756.95
0.77%
2.13

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

13.61
1.12
-2.12

EBITDA CAGR (%)

10 Years
5 Years
3 Years

14.68
-19.33
-2.16

PAT CAGR (%)

10 Years
5 Years
3 Years

-
-25.65
-10.11

P:E (Median)

8 Years
5 Years
3 Years

18.59
18.59
19.61

P:BV (Average)

8 Years
5 Years
3 Years

1.49
1.49
1.51

EV:EBITDA (Average)

8 Years
5 Years
3 Years

9.36
9.36
9.80

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 619.45 527.78 17.37% 580.39 523.30 10.91% 567.53 525.75 7.95% 551.69 502.38 9.82%
Expenses 526.88 464.84 13.35% 523.12 476.43 9.80% 510.43 484.19 5.42% 489.54 451.58 8.41%
EBITDA 92.57 62.94 47.08% 57.27 46.87 22.19% 57.10 41.56 37.39% 62.15 50.80 22.34%
EBIDTM 14.94% 11.93% 9.87% 8.96% 10.06% 7.90% 11.27% 10.11%
Other Income 1.74 4.52 -61.50% 5.29 4.07 29.98% 6.88 6.43 7.00% 7.37 7.38 -0.14%
Interest 3.21 4.03 -20.35% 3.63 4.46 -18.61% 3.48 4.12 -15.53% 4.23 2.15 96.74%
Depreciation 20.27 18.53 9.39% 20.17 18.66 8.09% 19.98 17.93 11.43% 19.75 16.80 17.56%
PBT 70.83 44.90 57.75% 27.55 27.82 -0.97% 40.52 25.94 56.21% 45.54 39.23 16.08%
Tax 17.65 13.28 32.91% 6.97 7.27 -4.13% 10.52 6.79 54.93% 11.58 9.55 21.26%
PAT 53.18 31.62 68.18% 20.58 20.55 0.15% 30.00 19.15 56.66% 33.96 29.68 14.42%
PATM 8.59% 5.99% 3.55% 3.93% 5.29% 3.64% 6.16% 5.91%
EPS 1.81 1.08 67.59% 0.70 0.70 0.00% 1.02 0.65 56.92% 1.16 1.01 14.85%

Description Mar 26 Mar 25 Var% Dec 25 Dec 24 Var% Sep 25 Sep 24 Var% Jun 25 Jun 24 Var%
Net Sales 619.45 527.78 17.37% 580.39 523.30 10.91% 567.53 525.75 7.95% 551.69 502.38 9.82%
Expenses 526.98 465.03 13.32% 523.11 476.43 9.80% 510.45 484.18 5.43% 489.55 451.27 8.48%
EBITDA 92.47 62.75 47.36% 57.28 46.87 22.21% 57.08 41.57 37.31% 62.14 51.11 21.58%
EBIDTM 14.93% 11.89% 9.87% 8.96% 10.06% 7.91% 11.26% 10.17%
Other Income 1.84 4.53 -59.38% 5.29 4.07 29.98% 6.88 6.43 7.00% 7.37 7.38 -0.14%
Interest 3.21 4.03 -20.35% 3.63 4.46 -18.61% 3.48 4.12 -15.53% 4.23 2.15 96.74%
Depreciation 20.29 18.55 9.38% 20.18 18.68 8.03% 19.99 17.94 11.43% 19.77 16.82 17.54%
PBT 70.81 44.70 58.41% 27.55 27.80 -0.90% 40.49 25.94 56.09% 45.51 39.52 15.16%
Tax 17.65 13.28 32.91% 6.97 7.27 -4.13% 10.52 6.79 54.93% 11.58 9.55 21.26%
PAT 53.16 31.42 69.19% 20.58 20.53 0.24% 29.97 19.15 56.50% 33.93 29.97 13.21%
PATM 8.58% 5.95% 3.55% 3.92% 5.28% 3.64% 6.15% 5.97%
EPS 1.81 1.07 69.16% 0.70 0.70 0.00% 1.02 0.65 56.92% 1.16 1.02 13.73%

Annual Results

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description TTM Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Net Sales 2,319.06 2,079.21 2,132.79 2,217.11 2,184.02 1,966.98 1,894.47 1,685.33 983.30 710.65 580.42 Net Sales Growth 11.54% -2.51% -3.80% 1.52% 11.03% 3.83% 12.41% 71.40% 38.37% 22.44% Cost Of Goods Sold 1,487.10 1,391.85 1,396.95 1,547.09 1,570.51 1,102.84 1,065.01 1,047.25 695.28 477.40 416.20 Gross Profit 831.96 687.36 735.84 670.02 613.51 864.14 829.46 638.08 288.02 233.25 164.21 GP Margin 35.87% 33.06% 34.50% 30.22% 28.09% 43.93% 43.78% 37.86% 29.29% 32.82% 28.29% Total Expenditure 2,049.97 1,877.04 1,901.27 1,990.59 1,927.74 1,375.14 1,320.59 1,275.68 863.77 608.45 529.04 Power & Fuel Cost - 114.93 149.05 131.98 78.18 51.46 65.12 63.94 45.66 37.45 46.57 % Of Sales - 5.53% 6.99% 5.95% 3.58% 2.62% 3.44% 3.79% 4.64% 5.27% 8.02% Employee Cost - 216.57 201.02 168.21 141.30 115.55 97.20 78.43 56.10 43.18 35.13 % Of Sales - 10.42% 9.43% 7.59% 6.47% 5.87% 5.13% 4.65% 5.71% 6.08% 6.05% Manufacturing Exp. - 47.39 47.67 43.07 36.86 28.13 28.37 25.68 22.57 16.77 8.83 % Of Sales - 2.28% 2.24% 1.94% 1.69% 1.43% 1.50% 1.52% 2.30% 2.36% 1.52% General & Admin Exp. - 8.08 8.99 6.52 5.12 4.48 2.86 2.63 1.39 1.19 1.17 % Of Sales - 0.39% 0.42% 0.29% 0.23% 0.23% 0.15% 0.16% 0.14% 0.17% 0.20% Selling & Distn. Exp. - 62.21 51.25 61.85 66.84 50.78 48.45 46.72 33.73 20.81 12.81 % Of Sales - 2.99% 2.40% 2.79% 3.06% 2.58% 2.56% 2.77% 3.43% 2.93% 2.21% Miscellaneous Exp. - 36.01 46.34 31.87 28.93 21.90 13.58 11.03 9.04 11.65 12.81 % Of Sales - 1.73% 2.17% 1.44% 1.32% 1.11% 0.72% 0.65% 0.92% 1.64% 1.44% EBITDA 269.09 202.17 231.52 226.52 256.28 591.84 573.88 409.65 119.53 102.20 51.38 EBITDA Margin 11.60% 9.72% 10.86% 10.22% 11.73% 30.09% 30.29% 24.31% 12.16% 14.38% 8.85% Other Income 21.28 22.40 30.07 25.57 32.04 24.30 16.02 10.37 6.33 1.25 1.23 Interest 14.55 14.76 16.10 16.47 8.29 5.83 20.93 51.42 64.35 67.68 61.47 Depreciation 80.17 71.92 62.85 46.13 43.26 38.92 35.73 32.45 30.21 29.84 29.69 PBT 184.44 137.89 182.64 189.49 236.77 571.39 533.24 336.15 31.30 5.93 -38.55 Tax 46.72 36.89 47.22 49.51 57.18 126.83 171.95 99.45 3.60 1.26 1.48 Tax Rate 25.33% 26.75% 25.85% 26.13% 25.66% 22.20% 32.25% 29.59% 11.50% 21.25% -3.84% PAT 137.72 101.00 135.42 139.98 165.66 444.56 361.29 236.70 27.70 4.67 -40.03 PAT before Minority Interest 137.72 101.00 135.42 139.98 165.66 444.56 361.29 236.70 27.70 4.67 -40.03 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.94% 4.86% 6.35% 6.31% 7.59% 22.60% 19.07% 14.04% 2.82% 0.66% -6.90% PAT Growth 36.36% -25.42% -3.26% -15.50% -62.74% 23.05% 52.64% 754.51% 493.15% - EPS 4.69 3.44 4.61 4.77 5.64 15.15 12.31 8.06 0.94 0.16 -1.36

Description TTM Mar 25 Mar 24 Mar 23 Mar 22
Net Sales 2,319.06 2,079.21 2,132.79 2,217.11 2,184.02 Net Sales Growth 11.54% -2.51% -3.80% 1.52% Cost Of Goods Sold 1,487.10 1,391.85 1,396.95 1,547.09 1,570.51 Gross Profit 831.96 687.36 735.84 670.02 613.51 GP Margin 35.87% 33.06% 34.50% 30.22% 28.09% Total Expenditure 2,050.09 1,876.91 1,902.20 1,991.44 1,925.73 Power & Fuel Cost - 114.93 149.05 131.98 78.18 % Of Sales - 5.53% 6.99% 5.95% 3.58% Employee Cost - 216.57 201.02 168.21 141.30 % Of Sales - 10.42% 9.43% 7.59% 6.47% Manufacturing Exp. - 47.39 47.67 43.07 36.86 % Of Sales - 2.28% 2.24% 1.94% 1.69% General & Admin Exp. - 8.10 9.01 6.54 5.12 % Of Sales - 0.39% 0.42% 0.29% 0.23% Selling & Distn. Exp. - 62.21 51.25 61.85 66.84 % Of Sales - 2.99% 2.40% 2.79% 3.06% Miscellaneous Exp. - 35.86 47.25 32.70 26.92 % Of Sales - 1.72% 2.22% 1.47% 1.23% EBITDA 268.97 202.30 230.59 225.67 258.29 EBITDA Margin 11.60% 9.73% 10.81% 10.18% 11.83% Other Income 21.38 22.41 30.07 25.61 32.04 Interest 14.55 14.76 16.10 16.47 8.29 Depreciation 80.23 71.99 62.91 46.16 43.26 PBT 184.36 137.96 181.65 188.65 238.78 Tax 46.72 36.89 47.22 49.51 57.18 Tax Rate 25.34% 26.74% 26.00% 26.24% 25.43% PAT 137.64 101.07 134.43 139.14 167.67 PAT before Minority Interest 137.64 101.07 134.43 139.14 167.67 Minority Interest 0.00 0.00 0.00 0.00 0.00 PAT Margin 5.94% 4.86% 6.30% 6.28% 7.68% PAT Growth 36.18% -24.82% -3.39% -17.02% EPS 4.69 3.44 4.58 4.74 5.71

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Shareholder's Funds 1,687.41 1,611.33 1,506.55 1,390.27 1,260.43 813.54 474.34 215.74 188.70 185.13 Share Capital 58.71 58.71 58.71 58.71 58.71 56.89 56.89 56.21 56.21 56.21 Total Reserves 1,628.70 1,552.62 1,447.84 1,331.56 1,201.72 747.33 408.13 159.53 132.49 128.92 Non-Current Liabilities 84.50 72.89 58.15 56.62 59.11 79.73 210.65 280.29 294.23 304.43 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 189.88 236.16 262.37 283.25 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 21.96 22.61 18.62 Long Term Provisions 6.69 6.71 1.65 3.01 3.68 3.85 4.59 2.04 1.50 1.18 Current Liabilities 638.54 596.85 502.17 575.29 432.80 453.63 324.79 350.97 327.67 282.92 Trade Payables 427.56 469.18 314.22 409.29 238.83 180.38 120.27 157.61 149.84 115.68 Other Current Liabilities 63.30 54.42 53.93 54.02 41.00 34.46 63.88 50.97 35.84 30.03 Short Term Borrowings 117.04 32.76 79.63 42.75 0.00 55.92 67.72 135.27 140.77 137.09 Short Term Provisions 30.64 40.49 54.39 69.23 152.97 182.87 72.92 7.12 1.22 0.13 Total Liabilities 2,410.45 2,281.07 2,066.87 2,022.18 1,752.34 1,346.90 1,009.78 847.00 810.60 772.48 Net Block 1,170.34 932.69 751.31 560.64 512.36 469.04 411.72 405.64 373.88 399.50 Gross Block 1,543.74 1,235.44 994.71 761.99 677.69 595.78 503.91 465.53 403.77 619.96 Accumulated Depreciation 373.40 302.75 243.40 201.35 165.33 126.74 92.19 59.89 29.89 220.47 Non Current Assets 1,230.66 1,124.49 1,101.54 881.58 600.19 498.99 457.60 416.02 395.94 415.63 Capital Work in Progress 21.93 100.87 89.64 105.20 48.27 19.19 27.02 6.95 21.26 4.31 Non Current Investment 17.71 17.71 17.71 0.10 0.00 0.00 0.00 0.00 0.05 0.04 Long Term Loans & Adv. 12.15 23.62 9.52 10.77 17.61 1.33 11.56 1.26 0.38 9.01 Other Non Current Assets 8.53 49.60 233.36 204.87 21.95 9.43 7.30 2.17 0.37 2.77 Current Assets 1,179.79 1,156.58 965.33 1,140.60 1,152.15 847.91 552.18 430.98 414.66 356.86 Current Investments 3.30 2.88 2.56 2.37 1.22 0.05 0.06 0.06 0.05 0.05 Inventories 360.62 424.84 325.52 409.89 295.15 187.52 188.86 207.45 262.63 227.94 Sundry Debtors 513.69 471.23 505.28 469.80 300.31 272.42 199.16 146.14 112.77 87.26 Cash & Bank 207.94 142.62 20.90 137.88 364.74 154.65 29.60 17.32 16.81 11.94 Other Current Assets 94.24 24.91 22.18 30.99 190.73 233.27 134.50 60.01 22.40 29.67 Short Term Loans & Adv. 67.33 90.10 88.89 89.67 152.21 208.87 126.88 56.79 18.79 26.78 Net Current Assets 541.25 559.73 463.16 565.31 719.35 394.28 227.39 80.01 86.99 73.93 Total Assets 2,410.45 2,281.07 2,066.87 2,022.18 1,752.34 1,346.90 1,009.78 847.00 810.60 772.49

Description Mar 25 Mar 24 Mar 23 Mar 22
Shareholder's Funds 1,687.66 1,611.51 1,507.72 1,392.28 Share Capital 58.71 58.71 58.71 58.71 Total Reserves 1,628.95 1,552.80 1,449.01 1,333.57 Non-Current Liabilities 84.50 72.89 58.15 56.62 Secured Loans 0.00 0.00 0.00 0.00 Unsecured Loans 0.00 0.00 0.00 0.00 Long Term Provisions 6.69 6.71 1.65 3.01 Current Liabilities 638.58 597.10 502.52 575.29 Trade Payables 427.56 469.18 314.22 409.29 Other Current Liabilities 63.34 54.67 54.28 54.02 Short Term Borrowings 117.04 32.76 79.63 42.75 Short Term Provisions 30.64 40.49 54.39 69.23 Total Liabilities 2,410.74 2,281.50 2,068.39 2,024.19 Net Block 1,170.71 933.13 751.81 560.64 Gross Block 1,544.27 1,235.97 995.24 761.99 Accumulated Depreciation 373.56 302.84 243.43 201.35 Non Current Assets 1,230.73 1,124.63 1,101.74 881.48 Capital Work in Progress 21.93 100.87 89.64 105.20 Non Current Investment 17.41 17.41 17.41 0.00 Long Term Loans & Adv. 12.15 23.62 9.52 10.77 Other Non Current Assets 8.53 49.60 233.36 204.87 Current Assets 1,180.01 1,156.87 966.65 1,142.71 Current Investments 3.30 2.88 2.56 2.37 Inventories 360.62 424.84 325.52 409.89 Sundry Debtors 513.69 471.23 505.28 469.80 Cash & Bank 208.15 142.89 21.83 139.99 Other Current Assets 94.25 24.91 29.86 30.99 Short Term Loans & Adv. 67.33 90.12 81.60 89.67 Net Current Assets 541.43 559.77 464.13 567.42 Total Assets 2,410.74 2,281.50 2,068.39 2,024.19

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Cash From Operating Activity 178.68 290.46 123.14 91.04 379.78 470.80 273.17 119.72 83.34 17.70 PBT 137.89 182.64 189.49 222.84 571.39 533.24 336.15 31.30 5.93 -38.55 Adjustment 79.78 59.76 44.42 33.12 27.15 51.93 82.35 91.64 95.92 83.92 Changes in Working Capital -20.67 90.08 -63.67 -102.34 -76.51 2.78 -77.64 3.14 -17.45 -27.67 Cash after chg. in Working capital 197.00 332.48 170.24 153.62 522.03 587.95 340.86 126.08 84.40 17.70 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -18.32 -42.02 -47.10 -62.58 -142.25 -117.15 -67.69 -6.36 -1.06 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -154.23 -191.39 -119.19 -120.62 -317.25 -184.23 -63.04 -50.38 -22.78 -27.37 Net Fixed Assets -229.36 -251.96 -217.16 -141.23 -110.99 -84.04 -58.45 -47.45 199.24 -25.77 Net Investments -0.42 -0.32 -17.80 -1.25 -1.17 0.01 0.00 0.04 -0.01 -0.04 Others 75.55 60.89 115.77 21.86 -205.09 -100.20 -4.59 -2.97 -222.01 -1.56 Cash from Financing Activity 46.04 -92.50 -4.11 -1.64 -58.28 -271.89 -197.46 -70.36 -59.78 9.27 Net Cash Inflow / Outflow 70.49 6.57 -0.16 -31.22 4.25 14.68 12.67 -1.02 0.78 -0.40 Opening Cash & Equivalents 7.53 0.96 1.12 32.34 28.09 13.41 0.74 1.76 0.98 1.38 Closing Cash & Equivalent 78.02 7.53 0.96 1.12 32.34 28.09 13.41 0.74 1.76 0.98

Description Mar 25 Mar 24 Mar 23 Mar 22
Cash From Operating Activity 178.62 289.78 122.27 93.05 PBT 137.96 181.65 188.65 224.85 Adjustment 79.85 59.82 44.41 33.12 Changes in Working Capital -20.87 90.33 -63.69 -102.34 Cash after chg. in Working capital 196.94 331.80 169.37 155.63 Interest Paid 0.00 0.00 0.00 0.00 Tax Paid -18.32 -42.02 -47.10 -62.58 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 Cash From Investing Activity -154.18 -190.98 -120.00 -120.52 Net Fixed Assets -229.36 -251.96 -217.16 Net Investments -0.42 -0.32 -17.80 Others 75.60 61.30 114.96 Cash from Financing Activity 46.04 -92.50 -4.11 -1.64 Net Cash Inflow / Outflow 70.48 6.30 -1.84 -29.11 Opening Cash & Equivalents 7.69 1.39 3.23 32.34 Closing Cash & Equivalent 78.17 7.69 1.39 3.23

Financial Ratios

Standalone /

Consolidated

Right to Left

Description Mar 25 Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16
Book Value (Rs.) 57.48 54.89 256.61 236.80 214.69 141.36 81.74 38.38 33.57 32.94 ROA 4.31% 6.23% 6.85% 8.78% 28.69% 30.66% 25.50% 3.34% 0.59% -5.43% ROE 6.12% 8.69% 9.66% 12.50% 43.06% 56.93% 69.54% 13.70% 2.50% -20.72% ROCE 8.85% 12.30% 13.64% 17.16% 54.20% 68.09% 55.53% 15.03% 11.57% 3.68% Fixed Asset Turnover 1.50 1.91 2.52 3.03 3.09 3.45 3.48 2.30 1.51 1.06 Receivable days 86.45 83.56 80.26 64.35 53.14 45.43 37.39 47.21 47.21 33.98 Inventory Days 68.94 64.21 60.53 58.91 44.78 36.26 42.92 85.71 115.79 125.04 Payable days 117.58 102.34 85.35 75.31 69.37 41.74 37.73 62.92 46.31 3.40 Cash Conversion Cycle 37.81 45.42 55.45 47.95 28.55 39.95 42.57 69.99 116.69 155.61 Total Debt/Equity 0.07 0.02 0.05 0.03 0.00 0.07 0.61 1.96 2.37 2.44 Interest Cover 10.34 12.34 12.51 27.88 99.01 26.48 7.54 1.49 1.09 0.37

Description Mar 25 Mar 24 Mar 23 Mar 22
Book Value (Rs.) 57.49 54.90 256.81 237.15 ROA 4.31% 6.18% 6.80% 8.28% ROE 6.13% 8.62% 9.60% 12.04% ROCE 8.86% 12.24% 13.57% 16.25% Fixed Asset Turnover 1.50 1.91 2.52 2.87 Receivable days 86.45 83.56 80.26 78.51 Inventory Days 68.94 64.21 60.53 68.50 Payable days 117.58 102.34 85.35 95.12 Cash Conversion Cycle 37.81 45.42 55.45 51.89 Total Debt/Equity 0.07 0.02 0.05 0.03 Interest Cover 10.35 12.28 12.45 28.12

Top Investors:

synthorix trading limited

Annual Reports:

News Update:

IOL Chem & Pharma - Quarterly Results
21st May 2026, 00:00 AM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback